# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093351
Filing Date
2024-08-08
Accepted
2024-08-08 08:05:23
Documents
54
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | pepg-20240630.htm iXBRL | 10-Q | 1997663
2 | EX-10.1 | pepg-ex10_1.htm | EX-10.1 | 16655
3 | EX-31.1 | pepg-ex31_1.htm | EX-31.1 | 18686
4 | EX-31.2 | pepg-ex31_2.htm | EX-31.2 | 17676
5 | EX-32.1 | pepg-ex32_1.htm | EX-32.1 | 7754
6 | EX-32.2 | pepg-ex32_2.htm | EX-32.2 | 7785
| Complete submission text file | 0000950170-24-093351.txt |  | 6279347

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | pepg-20240630.xsd | EX-101.SCH | 896374
56 | EXTRACTED XBRL INSTANCE DOCUMENT | pepg-20240630_htm.xml | XML | 721477

Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41374 | Film No.: 241186161
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)